SOUTH SAN FRANCISCO, Calif., Aug. 25, 2025 /PRNewswire/ -- IDEAYA Biosciences, Inc. (NASDAQ: IDYA), a precision medicine oncology company committed
Two-step screen + RT-qPCR validation yields AUC 0.94 (CRC) and 0.83 (advanced adenoma) in 114-sample pilot PLEASANTON, Calif., Aug. 25,
Two-step screen + RT-qPCR validation yields AUC 0.94 (CRC) and 0.83 (advanced adenoma) in 114-sample pilot PLEASANTON, Calif., Aug. 25,
Topline results anticipated in Q1 2026 and, if successful, planning for expedited NDA submission If approved, ampreloxetine could address a
Topline results anticipated in Q1 2026 and, if successful, planning for expedited NDA submission If approved, ampreloxetine could address a
WASHINGTON, Aug. 25, 2025 /PRNewswire/ -- Snoopy fans, rejoice! The viral Red Cross x PEANUTS limited-edition T-shirts are back with
CARY, N.C., Aug. 25, 2025 /PRNewswire/ -- InstantGMP™, a leading provider of manufacturing and quality management software for regulated industries,
MoU sets key performance parameters including return on net worth, return on capital employed, NPA to total loans, asset turnover